Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Strides Pharma Science: Nandini Matiyani joins as Executive VP - Human Resources

Strides Pharma shares sold by 2 entities for Rs 81 crore

Ruchika Sharma10 Feb 2024 1:30 PM IST

Bangalore: Two entities including Bajaj Finance have sold shares of Strides Pharma Science for Rs 81 crore through open market transactions. According...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

USFDA grants Breakthrough Therapy Designation for JnJ Nipocalimab for individuals at high risk for severe hemolytic disease of fetus, newborn

Ruchika Sharma10 Feb 2024 12:06 PM IST

Spring House: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation...

Zydus Lifesciences gets tentative USFDA approval for Dexamethasone Tablets USP, 1 mg

Ruchika Sharma10 Feb 2024 10:00 AM IST

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) to manufacture...

Indiscreet prescribing of antibiotics is key contributor to microbial resistance nationwide: MoS Health

Ruchika Sharma9 Feb 2024 8:36 PM IST

New Delhi: The Union Health Ministry has initiated several initiatives to promote judicious use of antimicrobials, as indiscreet prescribing of...

Biocon Gets USFDA Approval for Everolimus Oral Suspension in Pediatric, Adult TSC

Biocon registers consolidated revenue of Rs 4519 crore in Q3

Ruchika Sharma9 Feb 2024 4:03 PM IST

Bengaluru: Bengaluru, Biocon Ltd, the Bengaluru-based pharmaceutical giant has announced its consolidated financial results for the fiscal third...

Shilpa Medicare ink pact to sell 31 percent stake in Sravathi Advanced Process Technologies for Rs 49.6 crore

Mankind Pharma promoters divest 1.6 percent stake worth Rs 1367 crore

Ruchika Sharma9 Feb 2024 1:30 PM IST

New Delhi: Mankind Pharma promoters on Thursday divested a 1.62 per cent stake in the company for Rs 1,367 crore through open market...

Lupin Manufacturing Solutions, PolyPeptide Group forge long term Peptide alliance

Biocon Biologics, Sandoz Australia ink pact for biosimilars Trastuzumab, Bevacizumab

Ruchika Sharma9 Feb 2024 12:30 PM IST

Trastuzumab is a biosimilar of Herceptin and Bevacizumab is a biosimilar of Avastin - both biosimilars are available on the PBS and utilised for the...

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

Zydus Lifesciences bags USFDA nods for Dexamethasone Tablets USP, 0.5 mg, 0.75 mg, 1.5 mg, 4 mg and 6 mg and Dexamethasone Tablets USP, 2 mg

Ruchika Sharma9 Feb 2024 11:55 AM IST

Ahmedabad: Zydus Lifesciences Limited has received final approvals from the United States Food and Drug Administration (USFDA) to manufacture and...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

USFDA accepts under priority review GSK application to extend indication of adjuvanted RSV vaccine

Ruchika Sharma8 Feb 2024 4:30 PM IST

London: GSK plc has announced that the US Food and Drug Administration (FDA) has accepted under priority review an application to extend the...

Lupin receives positive EMA comittee opinion for eye therapy Ranluspec

Lupin posts bigger-than-expected rise in Q3 profit

Ruchika Sharma8 Feb 2024 2:30 PM IST

Mumbai: Indian generic drugmaker Lupin reported a bigger-than-expected rise in its third-quarter profit on Wednesday, helped by strong demand in...

NPPA Finally Allows GSK to Discontinue Grisovin FP

GSK application for Shingrix for shingles prevention in at-risk adults aged 18 and over accepted for review in China

Ruchika Sharma8 Feb 2024 1:30 PM IST

London: GSK plc has announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted...

Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for recurrent genital herpes

Gilead Sciences blood cancer therapy trials put on hold by USFDA

Ruchika Sharma8 Feb 2024 12:30 PM IST

The drug is an antibody treatment that blocks a type of protein, called CD47, which helps damaged cells avoid destruction by the immune system.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok